eNewsroom for: Cedarburg Hauser Pharmaceuticals

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Cedarburg Hauser Pharmaceuticals/Screen Shot 2012-09-25 at 8.17.50 AM.png

Cedarburg Hauser Pharmaceuticals Company Profile

Cedarburg Hauser Pharmaceuticals is an experienced, contract development and manufacturing company for active pharmaceutical ingredients (API) and pharmaceutical intermediates that combines the benefits of working with a contract research organization (CRO) and a contract manufacturing organization.

News from Cedarburg Hauser Pharmaceuticals:

Cedarburg Pharmaceuticals, Inc. to Be Acquired by Albany Molecular Research, Inc.

GRAFTON, Wis., March 24, 2014 /PRNewswire/ — Cedarburg Pharmaceuticals, Inc. today announced that it has signed a definitive agreement to be acquired by Albany Molecular Research Inc., a global contract research and manufacturing organization. The transaction is expected to close in early A…

Cedarburg Hauser Hires Alex Tretyakov as Director of Process Development

GRAFTON, Wis., Feb. 11, 2014 /PRNewswire/ – Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO) specializing in small molecule APIs, has announced the hire Alex Tretyakov, Ph.D. as its Director of Process Development.…

Cedarburg Hauser Upgrades API Manufacturing Plant

GRAFTON, Wis., Sept. 18, 2013 /PRNewswire/ — Cedarburg Hauser Pharmaceuticals (CHP) announces the improvement of its Active Pharmaceutical Ingredient (API) plant in Grafton, WI. These upgrades are a continuation of a long-term capital improvement initiative that results from an increased…

Cedarburg Hauser Pharmaceuticals Receives CMO Leadership Award in Productivity

GRAFTON, Wis., Aug. 8, 2013 /PRNewswire/ – Cedarburg Hauser Pharmaceuticals (CHP), a contract development and manufacturing organization (CDMO), announces the receipt of a CMO Leadership Award for excellence in productivity. This is the second consecutive year CHP has received an award i…

Cedarburg Hauser Granted DEA Registration for Denver Manufacturing Facility

DENVER, Feb. 27, 2013 /PRNewswire/ – Cedarburg Hauser Pharmaceuticals (CHP), a contract development and manufacturing organization (CDMO), announced today that its Denver, Colorado facility has been granted registration as a manufacturer of schedule II-V controlled substances by the U…

Cedarburg Hauser Promotes John K. Lynch to Chief Scientific Officer

GRAFTON, Wis., Nov. 6, 2012 /PRNewswire/ – Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO).
Dr. Lynch has served as Cedarburg Ha…

Cedarburg Hauser Adds Plant Capacity

Makes Additional Capital Investments in Response to Demand for Commercial API
GRAFTON, Wis., Sept. 25, 2012 /PRNewswire/ — Cedarburg Hauser Pharmaceuticals (CHP) has expanded the capacity of its Wisconsin-based active pharmaceutical ingredient (API) manufacturing plant. The expansion e…